Support Alert

Class 2 Medicines Recall: Molipaxin 100 mg capsules (one batch)

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 2 medicines recall for a single batch of Molipaxin 100 mg capsules, due to a potential issue with the metal detector during manufacture of the batch (EL(18) A/01).

Further details of the issue, the affected batch and action to take are available on the MHRA website.